National Administration of Medical Products nke China anabatala nke ọma maka ojiji Satọdee a ọgwụ mgbochi CoronaVac, nke ụlọ ọrụ na-ahụ maka ọgwụ Sinovac Biotech mepụtara, ọgwụ mgbochi nke abụọ nke nnukwu Asia mepụtara mgbe Sinopharm gasịrị. Mkpebi a dabere na nsonaazụ nke usoro nke atọ nke nnwale ụlọ ọgwụ, nke emebeghị ka ọha na eze ruo mgbe emechara data ha maka ịdị mma na nchekwa, onye na-ere ọgwụ n'onwe ya kọwara na nkwupụta nke akwụkwọ akụkọ China bụ Global Times chịkọtara.
Ụlọ ọrụ ahụ na-atụ anya inwe ike ịmepụta ihe karịrị 1,000 nde doses kwa afọ nke ụdị ọgwụ mgbochi a na-adịghị arụ ọrụ, nke sitere na nje virus na-enweghị ike ịmepụta ọrịa, mana nke na-emepụta nzaghachi mgbochi. A kwadoro ọgwụ mgbochi a maka ojiji mberede na China na June 2020 ma nwetakwa nkwado nwa oge site na Indonesia, Turkey, Brazil, Chile na Colombia. Ebunyelarị ọgwụ na Brazil, Indonesia, Turkey na Chile. China agbaala ọgwụ mgbochi 2.7% nke ndị bi na ya, dị ka data chịkọtara site na isi mmalite sitere na Worldwa anyị na Data Portal, jikọtara na Mahadum Oxford.
